Dong‐Wook Kim - Publications, H-index & Citations

Dong‐Wook Kim

uijeongbu eulji medical center

62H指数

604论文数

2.0W被引数

收录论文 86

发表时间

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results Asciminib单药治疗BCR::ABL1 T315I突变慢性期慢性粒细胞白血病：1期试验最终结果

Leukemia

IF13.4

2026-07-16

OAAI

Jorge E. Cortes; Delphine Rea; Michael J. Mauro; Andreas Hochhaus; Dong-Wook Kim; Koji Sasaki; Fabian Lang; Michael C. Heinrich; Massimo Breccia; Michael Deininger; Yeow-Tee Goh; Jeroen J. W. M. Janssen; Moshe Talpaz; Valle Gómez García de Soria; Philipp le Coutre; Francois-Xavier Mahon; Daniel J. DeAngelo; Andrea Damon; Shruti Kapoor; Gessami Sanchez-Olle; Matthias Hoch; Nithya Agrawal; Sara Quenet; Timothy P. Hughes

BCR::ABL1 tyrosine kinase inhibitors induce ribosome collisions to activate ZAK-dependent ribotoxic stress and apoptosis in chronic myeloid leukemia BCR::ABL1酪氨酸激酶抑制剂通过诱导核糖体碰撞来激活ZAK依赖性的核糖体毒性应激和凋亡，在慢性髓性白血病中发挥作用。

Leukemia

IF13.4

2026-03-30

OAAI

Jumin Park; Soo-Hyun Kim; Jongmin Park; Heeju Park; Hongtae Kim; Dong-Wook Kim; Chunghun Lim

Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis MUSASHI2-DEPTOR-KIF11轴对代谢适应和白血病进展的调控

Leukemia

IF13.4

2025-10-01

PREAI

Tania Setiawan; Jabir Aliyu Muhammad; Nadya Marcellina; Lawrence Mario Wirawan; Nayoung Jun; Ita Novita Sari; Vivian G. Oehler; Dong-Wook Kim; Hyog Young Kwon

Microfluidic Single-Cell Drug Screening: Toward Personalized Precision Therapy in Chronic Myeloid Leukemia 微流控单细胞药物筛选：慢性髓系白血病个体化精准疗法的方向

lab on a chip

IF0

2025-09-20

PREAI

Hwisu Jeon; Yukyung Park; Soo-Hyun Kim; Chang-Yeol Jung; Hongtae Kim; Eujin Um; Dong-Wook Kim; Taesung Kim

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia 2025欧洲白血病网关于慢性粒细胞白血病治疗的建议

Leukemia

IF13.4

2025-07-11

OAAI

Jane F. Apperley; Dragana Milojkovic; Nicholas C. P. Cross; Henrik Hjorth-Hansen; Andreas Hochhaus; Hagop Kantarjian; Jeffrey H. Lipton; Hemant Malhotra; Dietger Niederwieser; Jerald Radich; Philippe Rousselot; Susanne Saussele; Charles A. Schiffer; Richard Silver; Simona Soverini; Leif Stenke; Anna Turkina; Luis Felipe Casado; Fausto Castagnetti; Francisco Cervantes; Richard E. Clark; Jorge Cortes; Michael Deininger; Timothy P. Hughes; Jeroen Janssen; Qian Jiang; Dong-Wook Kim; Richard A. Larson; Francois X. Mahon; Michael Mauro; Jiri Mayer; Franck E. Nicolini; Fabrizio Pane; Delphine Rea; Johan Richter; Gianantonio Rosti; Giuseppe Saglio; Rüdiger Hehlmann

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL Asciminib在ASCEMBL研究中经过近4年的随访后，在晚期慢性粒细胞白血病慢性期（CML-CP）中仍优于bosutinib。

Blood Advances

IF7.1

2025-05-09

OAAI

Michael J. Mauro; Yosuke Minami; Andreas Hochhaus; Elza Lomaia; Sergey Voloshin; Anna Turkina; Dong-Wook Kim; Jane F. Apperley; Jorge E. Cortes; Andre Abdo; Laura Maria Fogliatto; Dennis Dong Hwan Kim; Philipp le Coutre; Susanne Saussele; Mario Annunziata; Timothy P. Hughes; Naeem Chaudhri; Lynette Chee; Valentin García-Gutiérrez; Koji Sasaki; Carla Boquimpani; Shruti Kapoor; Noemi Espurz; Vishal Dhamal; Delphine Rea

KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia KF1601，一种BCR::ABL1和FLT3的双抑制剂，克服了FLT3+急变期慢性髓性白血病的药物抵抗。

MOLECULAR CANCER

IF33.9

2025-04-14

OAAI

Kwon, Hyun-Jin; Shin, Ji Eun; Khan, Amir; Park, So Yeon; Kim, Jiyoung; Lee, Jee-Young; Lee, Doohyun; Lee, Seungyeon; Im, Chun Young; Moon, Heegyum; Han, Ye Ri; Tamai, Minori; Akahane, Koshi; Inukai, Takeshi; Lee, Wonhwa; Kim, Hyelim; Kim, Hong Nam; Ahn, Sung-Min; Park, Hyun Woo; Kim, Dong-Wook

Continuous manufacturing and process analytical technology: focusing on dosage forms with improved solubility and controlled release 连续制造和过程分析技术: 专注于具有改善的溶解度和控制释放的剂型

JOURNAL OF PHARMACEUTICAL INVESTIGATION

IF5.1

2025-03-01

PREAI

Seok, Su Hyun; Yoo, Seung-Dong; Kim, Dong-Wook; Lee, In-Ah; Min, Kyung Hyun; Kang, Ji-Hyun; Park, Chun-Woong; Kim, Ju-Young; Park, Eun-Seok

Novel Microfluidic and AI-Based Approach for Personalized Drug Selection in Chronic Myeloid Leukemia (CML) Patients 基于微流控和人工智能的新方法用于慢性髓性白血病(CML)患者的个性化药物选择

BLOOD

IF23.1

2024-11-05

PREAI

Jeon, Hwisu; Park, Yukyung; Um, Eujin; Kim, Hongtae; Jung, Chang-Yeol; Kim, Dong-Wook; Kim, Taesung

A line attractor encoding a persistent internal state requires neuropeptide signaling 编码持续内部状态的线吸引子需要神经肽信号传导

CELL

IF42.5

2024-10-01

OAAI

Mountoufaris, George; Nair, Aditya; Yang, Bin; Kim, Dong-Wook; Vinograd, Amit; Kim, Samuel; Linderman, Scott W.; Anderson, David J.

REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity

LEUKEMIA

IF13.4

2024-07-30

OAAI

Lee, Ye Jin; Lee, Seo Yun; Kim, Soomi; Kim, Soo-Hyun; Lee, Soo Hyeon; Park, Sungho; Kim, Jae Jin; Kim, Dong-Wook; Kim, Hongtae

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results 在酪氨酸激酶抑制剂治疗 ≥ 1个T315I突变的慢性期慢性粒细胞白血病患者中单药治疗: 2年随访结果

LEUKEMIA

IF13.4

2024-05-16

OAAI

Cortes, Jorge E.; Sasaki, Koji; Kim, Dong-Wook; Hughes, Timothy P.; Etienne, Gabriel; Mauro, Michael J.; Hochhaus, Andreas; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow Tee; Janssen, Jeroen J. W. M.; Talpaz, Moshe; de Soria, Valle Gomez Garcia; le Coutre, Philipp; Deangelo, Daniel J.; Damon, Andrea; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Rea, Delphine

Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to 3 months of imatinib therapy: final 5-year results from DASCERN

HAEMATOLOGICA

IF7.9

2024-05-02

OAAI

Cortes, Jorge E.; Jiang, Qian; Wang, Jianxiang; Weng, Jianyu; Zhu, Huanling; Liu, Xiaoli; Hochhaus, Andreas; Kim, Dong-Wook; Radich, Jerald; Savona, Michael; Martin-Regueira, Patricia; Sy, Oumar; Saglio, Giuseppe

Brain-Decellularized ECM-Based 3D Myeloid Sarcoma Platform: Mimicking Adaptive Phenotypic Alterations in the Brain

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-02-13

PREAI

Yoon, Heejeong; Kang, Joo H.; Cho, Seung Woo; Park, Chun Gwon; Kim, Dong-Wook; Park, Tae-Eun

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus 出生与第二针乙肝疫苗接种间隔对乙肝病毒围产期传播的影响

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2023-11-13

OAAI

Yang, Tae Un; Vargas-Zambrano, Juan C.; Park, Hang A.; Jung, Chae Won; Kim, Dongwook; Jee, Youngmee

Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia 靶向FLT3-TAZ信号抑制急变期慢性粒细胞白血病耐药

MOLECULAR CANCER

IF33.9

2023-11-06

OAAI

Shin, Ji Eun; Kim, Soo-Hyun; Kong, Mingyu; Kim, Hwa-Ryeon; Yoon, Sungmin; Kee, Kyung-Mi; Kim, Jung Ah; Kim, Dong Hyeon; Park, So Yeon; Park, Jae Hyung; Kim, Hongtae; No, Kyoung Tai; Lee, Han-Woong; Gee, Heon Yung; Hong, Seunghee; Guan, Kun-Liang; Roe, Jae-Seok; Lee, Hyunbeom; Kim, Dong-Wook; Park, Hyun Woo

Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results Asciminib单药治疗无BCR的cml-cp患者::ABL1 T315I突变与至少两个先前的TKIs治疗: 4年1期安全性和有效性结果

LEUKEMIA

IF13.4

2023-03-22

OAAI

Mauro, Michael J.; Hughes, Timothy P.; Kim, Dong-Wook; Rea, Delphine; Cortes, Jorge E.; Hochhaus, Andreas; Sasaki, Koji; Breccia, Massimo; Talpaz, Moshe; Ottmann, Oliver; Minami, Hironobu; Goh, Yeow Tee; DeAngelo, Daniel J.; Heinrich, Michael C.; Gomez-Garcia de Soria, Valle; le Coutre, Philipp; Mahon, Francois-Xavier; Janssen, Jeroen J. W. M.; Deininger, Michael; Shanmuganathan, Naranie; Geyer, Mark B.; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Hoch, Matthias; Lang, Fabian

Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL 在先前用至少两种酪氨酸激酶抑制剂治疗的慢性粒细胞白血病的慢性期中，Asciminib vs bos sutinib: ASCEMBL的长期随访

LEUKEMIA

IF13.4

2023-01-30

OAAI

Hochhaus, Andreas; Rea, Delphine; Boquimpani, Carla; Minami, Yosuke; Cortes, Jorge E.; Hughes, Timothy P.; Apperley, Jane F.; Lomaia, Elza; Voloshin, Sergey; Turkina, Anna; Kim, Dong-Wook; Abdo, Andre; Fogliatto, Laura Maria; le Coutre, Philipp; Sasaki, Koji; Kim, Dennis Dong Hwan; Saussele, Susanne; Annunziata, Mario; Chaudhri, Naeem; Chee, Lynette; Garcia-Gutierrez, Valentin; Kapoor, Shruti; Allepuz, Alex; Quenet, Sara; Bedoucha, Veronique; Mauro, Michael J.

Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia

NEOPLASIA

IF7.7

2022-10-01

OAAI

Kim, Eunjung; Hwang, Eo-Jin; Lee, Junghye; Kim, Dae-Young; Kim, Jae-Young; Kim, Dong-Wook

Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee (vol 15, 1, 2022)

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2022-03-23

OAAI

Januzzi, James L.; Garasic, Joseph M.; Kasner, Scott E.; McDonald, Vickie; Petrie, Mark C.; Seltzer, Jonathan; Mauro, Michael; Croce, Kevin; Berman, Ellin; Deininger, Michael; Hochhaus, Andreas; Pinilla-Ibarz, Javier; Nicolini, Franck; Kim, Dong-Wook; DeAngelo, Daniel J.; Kantarjian, Hagop; Xu, Jing; Hall, Tracey; Srivastava, Shouryadeep; Naranjo, Daniel; Cortes, Jorge

研究方向